104 related articles for article (PubMed ID: 37784249)
1. Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas.
Liu W; Yang HS; Zhi FH; Feng YF; Luo HH; Zhu Y; Lei YY
Clin Transl Med; 2023 Oct; 13(10):e1368. PubMed ID: 37784249
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor α-Dependent Lung Inflammation Promotes the Progression of Lung Adenocarcinoma Originating From Alveolar Type II Cells by Upregulating MIF-CD74.
Cao L; Wang X; Liu X; Meng W; Guo W; Duan C; Liang X; Kang L; Lv P; Lin Q; Zhang R; Zhang X; Shen H
Lab Invest; 2023 Mar; 103(3):100034. PubMed ID: 36925198
[TBL] [Abstract][Full Text] [Related]
4. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
[TBL] [Abstract][Full Text] [Related]
5. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
6. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
Wei S; Xing J; Lu K; Wang K; Yu W
Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
[TBL] [Abstract][Full Text] [Related]
7. Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma.
Fan T; Zhu M; Wang L; Liu Y; Tian H; Zheng Y; Tan F; Sun N; Li C; He J
Aging (Albany NY); 2020 Dec; 13(2):2397-2417. PubMed ID: 33318300
[TBL] [Abstract][Full Text] [Related]
8. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
9. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
10. Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas.
Gomes M; Archer F; Girard N; Gineys B; Dolmazon C; Bobet Erny A; Mornex JF; Leroux C
Vet Res; 2017 Nov; 48(1):76. PubMed ID: 29137669
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time.
Liu D; Yao L; Ding X; Zhou H
Comput Biol Med; 2023 Sep; 164():107333. PubMed ID: 37586202
[TBL] [Abstract][Full Text] [Related]
12. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer-associated fibroblasts and immune and metabolism microenvironment.
Wei S; Bao M; Zhu Y; Zhang W; Jiang L
Environ Toxicol; 2023 Aug; 38(8):1951-1967. PubMed ID: 37186041
[TBL] [Abstract][Full Text] [Related]
13. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Kamimura A; Kamachi M; Nishihira J; Ogura S; Isobe H; Dosaka-Akita H; Ogata A; Shindoh M; Ohbuchi T; Kawakami Y
Cancer; 2000 Jul; 89(2):334-41. PubMed ID: 10918163
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway.
Huang WC; Kuo KT; Wang CH; Yeh CT; Wang Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):180. PubMed ID: 31036057
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract][Full Text] [Related]
16. Immune cell infiltration features and related marker genes in lung cancer based on single-cell RNA-seq.
Zhong R; Chen D; Cao S; Li J; Han B; Zhong H
Clin Transl Oncol; 2021 Feb; 23(2):405-417. PubMed ID: 32656582
[TBL] [Abstract][Full Text] [Related]
17. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
18. 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy/pSTAT3.
Liu Y; Zhang H; Wang Z; Wu P; Gong W
Eur J Cancer; 2019 Jun; 114():8-24. PubMed ID: 31009821
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
20. MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1.
Wang A; Fan F; Zang C; Li C; Hong H; Wang Z; Gao Y; Chen L; Yu X; Zhou C; Zhao C
Hum Gene Ther; 2023 Jun; 34(11-12):540-553. PubMed ID: 37183407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
